Proapoptotic activity of heterocyclic compounds containing succinimide moiety in the promyelocytic leukemia cell line HL-60.

Bozena Kuran, Mariola Krawiecka, Jerzy Kossakowski, Mirosława Koronkiewicz, Zdzisław Chilmonczyk

Department of Medical Chemistry, Medical University of Warsaw, 3 Oczki St., 02-007 Warszawa, Poland. bozena.kuran@interia.pl

Acta poloniae pharmaceutica 2013 May-Jun

filter terms:

In the present paper, we describe proapoptotic activity of several heterocyclic compounds 9, 12, 18, 19 and 20 possessing succinimide (as well as succinimide related) moieties. The compounds properties were examined with the aid of flow cytometry on the promyelocytic leukemia cell line HL-60. The highest proapoptotic activity exhibited compound 12 (4-{4-[4-(2-methoxyphenyl)piperazin-1-yl]butyl}-1,7-diethyl-8,9-diphenyl-4-azatricyklo[5.2.1.0(2,6)]-dec-8-ene-3,5,10-trione). The synthesis of compounds 1-17 is also described. The structures of obtained compounds were characterized by 1H NMR, 13C NMR, ESI MS and/or elemental analyses.

Citation

Bozena Kuran, Mariola Krawiecka, Jerzy Kossakowski, Mirosława Koronkiewicz, Zdzisław Chilmonczyk. Proapoptotic activity of heterocyclic compounds containing succinimide moiety in the promyelocytic leukemia cell line HL-60. Acta poloniae pharmaceutica. 2013 May-Jun;70(3):459-68